CSN3 Antibody, HRP conjugated
-
中文名稱：CSN3兔多克隆抗體, HRP偶聯(lián)
-
貨號(hào)：CSB-PA006064LB01HU
-
規(guī)格：￥880
-
其他：
產(chǎn)品詳情
-
產(chǎn)品名稱：Rabbit anti-Homo sapiens (Human) CSN3 Polyclonal antibody
-
Uniprot No.：
-
基因名：CSN3
-
別名：CSN3 antibody; CASK antibody; CSN10 antibody; CSNK antibody; Kappa-casein antibody
-
宿主：Rabbit
-
反應(yīng)種屬：Human
-
免疫原：Recombinant Human Kappa-casein protein (24-182AA)
-
免疫原種屬：Homo sapiens (Human)
-
標(biāo)記方式：HRP
-
克隆類型：Polyclonal
-
抗體亞型：IgG
-
純化方式：>95%, Protein G purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 -
產(chǎn)品提供形式：Liquid
-
應(yīng)用范圍：ELISA
-
Protocols：
-
儲(chǔ)存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產(chǎn)品評(píng)價(jià)
相關(guān)產(chǎn)品
靶點(diǎn)詳情
-
功能：Kappa-casein stabilizes micelle formation, preventing casein precipitation in milk.
-
基因功能參考文獻(xiàn)：
- CSN3 was found to contain an interesting coding polymorphism as well as containing excess rare variation as compared with the other genes evaluated in cerebral ischemia patients. PMID: 22536414
- The recombinant Caseinomacropeptide (hCMP)has been produced as a secretory product in yeast and was estimated to be 7.0kDa by SDS-PAGE, and showed a lower glycosylation than the natural bovine CMP. PMID: 15866733
- human milk plasma protein exterts an apoptotic effect on MCF-7 adenocarcinoma cells. PMID: 18505157
-
亞細(xì)胞定位：Secreted.
-
蛋白家族：Kappa-casein family
-
組織特異性：Mammary gland specific. Secreted in milk.
-
數(shù)據(jù)庫(kù)鏈接：
Most popular with customers
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
-
-
